These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38712947)

  • 1. Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial.
    Bouchi R; Izumi K; Ishizuka N; Uemura Y; Ohtsu H; Miyo K; Tanaka S; Satoh-Asahara N; Hara K; Odawara M; Kusunoki Y; Koyama H; Onoue T; Arima H; Tsushita K; Watada H; Kadowaki T; Ueki K
    J Diabetes Investig; 2024 May; ():. PubMed ID: 38712947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of an app-based intervention on physical activity and glycemic control in people with type 2 diabetes.
    Kim G; Kim S; Lee YB; Jin SM; Hur KY; Kim JH
    BMC Med; 2024 May; 22(1):185. PubMed ID: 38693528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients: Nagoya Health Navigator Study protocol.
    Onoue T; Goto M; Kobayashi T; Tominaga T; Ando M; Honda H; Yoshida Y; Tosaki T; Yokoi H; Kato S; Maruyama S; Arima H
    Nagoya J Med Sci; 2017 Aug; 79(3):323-329. PubMed ID: 28878437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated Feedback Messages With Shichifukujin Characters Using IoT System-Improved Glycemic Control in People With Diabetes: A Prospective, Multicenter Randomized Controlled Trial.
    Kobayashi T; Tsushita K; Nomura E; Muramoto A; Kato A; Eguchi Y; Onoue T; Goto M; Muto S; Yatsuya H; Arima H
    J Diabetes Sci Technol; 2019 Jul; 13(4):796-798. PubMed ID: 31104490
    [No Abstract]   [Full Text] [Related]  

  • 5. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
    Agarwal P; Mukerji G; Desveaux L; Ivers NM; Bhattacharyya O; Hensel JM; Shaw J; Bouck Z; Jamieson T; Onabajo N; Cooper M; Marani H; Jeffs L; Bhatia RS
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10321. PubMed ID: 30632972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
    Rosenstock J; Frias J; Jastreboff AM; Du Y; Lou J; Gurbuz S; Thomas MK; Hartman ML; Haupt A; Milicevic Z; Coskun T
    Lancet; 2023 Aug; 402(10401):529-544. PubMed ID: 37385280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes: A Randomized Clinical Trial.
    Lim SL; Ong KW; Johal J; Han CY; Yap QV; Chan YH; Chooi YC; Zhang ZP; Chandra CC; Thiagarajah AG; Khoo CM
    JAMA Netw Open; 2021 Jun; 4(6):e2112417. PubMed ID: 34081137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial.
    Wild SH; Hanley J; Lewis SC; McKnight JA; McCloughan LB; Padfield PL; Parker RA; Paterson M; Pinnock H; Sheikh A; McKinstry B
    PLoS Med; 2016 Jul; 13(7):e1002098. PubMed ID: 27458809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
    Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
    Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle intervention using Internet of Things (IoT) for the elderly: A study protocol for a randomized control trial (the BEST-LIFE study).
    Kato S; Ando M; Kondo T; Yoshida Y; Honda H; Maruyama S
    Nagoya J Med Sci; 2018 May; 80(2):175-182. PubMed ID: 29915435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
    Sahay RK; Giri R; Shembalkar JV; Gupta SK; Mohan B; Kurmi P; Kumar SR; Sawardekar VM; Mishra A; Murthy LS; Arya VV; Sonawane AR; Soni PN; Gofne SK; Karnawat SR; Rajurkar MN; Patel PM; Lakhwani LK; Mehta SC; Joglekar SJ
    Adv Ther; 2023 Jul; 40(7):3227-3246. PubMed ID: 37258803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Kobayashi Y; Long J; Dan S; Johannsen NM; Talamoa R; Raghuram S; Chung S; Kent K; Basina M; Lamendola C; Haddad F; Leonard MB; Church TS; Palaniappan L
    Diabetologia; 2023 Oct; 66(10):1897-1907. PubMed ID: 37493759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Wearable Technology Delivering a Web-Based Diabetes Prevention Program to People at High Risk of Type 2 Diabetes: Randomized Controlled Trial.
    Staite E; Bayley A; Al-Ozairi E; Stewart K; Hopkins D; Rundle J; Basudev N; Mohamedali Z; Ismail K
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e15448. PubMed ID: 32459651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Prevention and Weight Loss with a Fully Automated Behavioral Intervention by Email, Web, and Mobile Phone: A Randomized Controlled Trial Among Persons with Prediabetes.
    Block G; Azar KM; Romanelli RJ; Block TJ; Hopkins D; Carpenter HA; Dolginsky MS; Hudes ML; Palaniappan LP; Block CH
    J Med Internet Res; 2015 Oct; 17(10):e240. PubMed ID: 26499966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
    Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Group Patient Education on Glycemic Control Among People Living with Type 2 Diabetes in Vietnam: A Randomized Controlled Single-Center Trial.
    Thanh HTK; Tien TM
    Diabetes Ther; 2021 May; 12(5):1503-1521. PubMed ID: 33840068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.